A prospective, observational, cohort study analysing whether early vedolizumab trough levels can predict clinical response
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- 10 Jul 2020 New trial record
- 19 May 2020 Results published at the Digestive Disease Week 2020